“…It was not until 2017 that siloxane moieties were rst graed onto lipid structures with the express purpose of modifying the lipids' interfacial behaviour. [32][33][34] Siloxane-phospholipids (SiPCs) possessing identical lipid tail structures to biologically relevant lipid species self-assemble in aqueous media to form low dispersity, unilamellar vesicles (ULVs) that are on average 120 nm in diameter, unlike natural phosphocholines such as 1,2dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-dioleoylsn-3-glycerophosphocholine (DOPC), or 1-palmitoyl-2-oleoyl-snglycero-3-phosphocholine (POPC), which typically form larger (>200 nm) multilamellar liposomes. Hybrid SiPCs, possessing a siloxane fatty acid tail in the sn-2 position and an aliphatic fatty acid tail in the sn-1 position, self-assembled into ULVs or multilamellar vesicles (MLVs) depending on the chain length of the sn-1 fatty acid.…”